Conspectus The use of nanoparticles (NPs) in biology and medicine requires a molecular-
level understanding of how NPs interact with cells in a physiological environment. A critical …

While the blood vessel is seldom the target tissue, almost all nanomedicine will interact with
blood vessels and blood at some point of time along its life cycle in the human body …

Although a wide variety of nanoparticles (NPs) have been engineered for use as disease
markers or drug delivery agents, the number of nanomedicines in clinical use has hitherto …

The protein compositions, or the proteomes, found in human salivary and plasma fluids are
compared. From recent experimental work by many laboratories, a catalogue of 2290 …

A method (denoted SISCAPA) for quantitation of peptides in complex digests is described. In
the method, anti-peptide antibodies immobilized on 100 nanoliter nanoaffinity columns are …

Human blood plasma can be obtained relatively noninvasively and contains proteins from
most, if not all, tissues of the body. Therefore, an extensive, quantitative catalog of plasma …

We have merged four different views of the human plasma proteome, based on different
methodologies, into a single nonredundant list of 1175 distinct gene products. The …

The Maillard reaction, starting from the glycation of protein and progressing to the formation
of advanced glycation end-products (AGEs), is implicated in the development of …

There is a direct correlation between protein levels and disease states in human serum,
which makes it an attractive target for sensors and diagnostics. However, this is challenging …

The evaluation of serum proteins and their electrophoretic pattern is a well-established
laboratory method in the diagnosis of many diseases in humans, which has replaced the …